← All trials
NCT03005418
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2018
- Primary completion
- Sep 1, 2027
- Completion date
- Sep 1, 2027
- First posted
- Dec 29, 2016
- Last posted
- Nov 2, 2023
- Enrollment
- 72
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Humacyte, Inc.Lead sponsor
- Atlantic Research GroupCollaborator
- Humacyte, Inc.Official
- United States ArmyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.